Syndax Pharmaceuticals, Inc. (SNDX)
9.54
+0.17
(+1.81%)
USD |
NASDAQ |
Nov 06, 16:00
9.79
+0.25
(+2.62%)
After-Hours: 20:00
Syndax Pharmaceuticals Total Liabilities (Quarterly) : 709.85M for Sept. 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 709.85M |
| June 30, 2026 | 688.55M |
| March 31, 2026 | 431.05M |
| December 31, 2025 | 465.08M |
| September 30, 2025 | 436.36M |
| June 30, 2025 | 438.72M |
| March 31, 2025 | 425.65M |
| December 31, 2024 | 436.69M |
| September 30, 2024 | 59.38M |
| June 30, 2024 | 42.61M |
| March 31, 2024 | 51.14M |
| December 31, 2023 | 58.68M |
| September 30, 2023 | 40.04M |
| June 30, 2023 | 31.30M |
| March 31, 2023 | 24.32M |
| December 31, 2022 | 29.79M |
| September 30, 2022 | 21.58M |
| June 30, 2022 | 44.50M |
| March 31, 2022 | 47.67M |
| December 31, 2021 | 41.29M |
| September 30, 2021 | 40.50M |
| June 30, 2021 | 48.50M |
| March 31, 2021 | 51.47M |
| December 31, 2020 | 48.42M |
| September 30, 2020 | 47.33M |
| Date | Value |
|---|---|
| June 30, 2020 | 44.98M |
| March 31, 2020 | 51.65M |
| December 31, 2019 | 31.92M |
| September 30, 2019 | 32.34M |
| June 30, 2019 | 32.12M |
| March 31, 2019 | 30.77M |
| December 31, 2018 | 30.89M |
| September 30, 2018 | 32.19M |
| June 30, 2018 | 35.02M |
| March 31, 2018 | 33.01M |
| December 31, 2017 | 32.87M |
| September 30, 2017 | 27.78M |
| June 30, 2017 | 25.33M |
| March 31, 2017 | 25.05M |
| December 31, 2016 | 24.87M |
| September 30, 2016 | 23.90M |
| June 30, 2016 | 21.62M |
| March 31, 2016 | 22.41M |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | 14.90M |
| June 30, 2014 | 5.35M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 406.66M |
| Emergent BioSolutions, Inc. | 682.00M |
| Incyte Corp. | 1.644B |
| Vertex Pharmaceuticals, Inc. | 11.83B |
| Travere Therapeutics, Inc. | 825.64M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 692.67M |
| Shareholders Equity (Quarterly) | -17.18M |
| Debt to Equity Ratio | -34.31 |
| Current Ratio | 4.691 |
| Net Debt Paydown Yield | -2.88% |